Jingqi Zeng, Xiaobin Jia. Quantifying compatibility mechanisms in traditional Chinese medicine with interpretable graph neural networks[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101342
Citation:
Jingqi Zeng, Xiaobin Jia. Quantifying compatibility mechanisms in traditional Chinese medicine with interpretable graph neural networks[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101342
Jingqi Zeng, Xiaobin Jia. Quantifying compatibility mechanisms in traditional Chinese medicine with interpretable graph neural networks[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101342
Citation:
Jingqi Zeng, Xiaobin Jia. Quantifying compatibility mechanisms in traditional Chinese medicine with interpretable graph neural networks[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101342
a. School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China;
b. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, China
Funds:
This research was supported by the National Natural Science Foundation of China (Grant No.: 82230117). This work benefited from the integration of data from numerous open-access and authoritative databases. We acknowledge the valuable contributions of resources such as DrugBank, BindingDB, BioGRID, DisGeNET, and many others. These datasets provided essential insights into TCM, modern drug chemistry, genetics, diseases, and related fields, forming the foundation for the traditional Chinese medicine multi-dimensional knowledge graph (TCM-MKG) used in this study. Furthermore, we utilized the PSICHIC model (https://github.com/huankoh/PSICHIC) to analyze the binding interactions between components and targets. Full citations for these resources are included in the manuscript.
Traditional Chinese medicine (TCM) features complex compatibility mechanisms involving multi-component, multi-target, and multi-pathway interactions. This study presents an interpretable graph artificial intelligence (GraphAI) framework to quantify such mechanisms in Chinese herbal formulas (CHFs). A multidimensional TCM knowledge graph (TCM-MKG;https://zenodo.org/records/13763953) was constructed, integrating seven standardized modules: TCM terminology, Chinese patent medicine (CPM), Chinese herbal pieces (CHPs), pharmacognostic origins (POs), chemical compounds, biological targets, and diseases. A neighbor-diffusion strategy was used to address the sparsity of compound-target associations, increasing target coverage from 12.0% to 98.7%. Graph neural networks (GNNs) with attention mechanisms were applied to 6,080 CHFs, modeled as graphs with CHPs as nodes. To embed domain-specific semantics, virtual nodes medicinal properties—therapeutic nature, flavor, and meridian tropism—were introduced, enabling interpretable modeling of inter-CHP relationships. The model quantitatively captured classical compatibility roles such as “sovereign-minister-assistant-courier,” and uncovered TCM etiological types derived from diagnostic and efficacy patterns. Model validation using 215 CHFs used for coronavirus disease 2019 (COVID-19) management highlighted Radix Astragali-Rhizoma Phragmitis as a high-attention herb pair. Mass spectrometry and target prediction identified three active compounds—Methylinissolin-3-O-glucoside, Corydalin, and Pingbeinine—which converge on pathways such as neuroactive ligand-receptor interaction, xenobiotic response, and neuronal function, supporting their neuroimmune and detoxification potential. Given their high safety and dietary compatibility, this herb pair may offer therapeutic value for managing long COVID-19. All data and code are openly available (https://github.com/ZENGJingqi/GraphAI-for-TCM), providing a scalable, interpretable platform for TCM mechanism research and discovery of bioactive herbal constituents.